Literature DB >> 9057797

Renal abnormalities in ankylosing spondylitis.

M J Vilar1, S E Cury, M B Ferraz, R Sesso, E Atra.   

Abstract

Renal abnormalities have been reported in Ankylosing Spondylitis (AS) patients. Possible mechanisms include the effects of nonsteroidal anti-inflammatory drugs (NSAIDs), an increased incidence of glomerulonephritis, particularly the ones associated with deposition of IgA-containing immune complexes and the renal deposition of amyloid. These observations prompted us to evaluate in detail the frequency and severity of renal dysfunction in 40 AS patients, consecutively selected attending the rheumatology disease unit outpatient clinic at Escola Paulista de Medicina, using sensitive tests of glomerular and tubular function. Fourteen of the 40 patients presented one or more signs of renal involvement: microscopic hematuria (9 patients), microalbuminuria (4 patients), decreased renal function assessed by serum creatinine (2 patients), and creatinine clearance (4 patients). None of the patients presented increased urinary excretion of retinol binding protein (RBP). The finding of renal abnormalities in 35% of our patients suggests that in this illness evidence of renal involvement should be actively investigated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057797     DOI: 10.3109/03009749709065659

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  14 in total

1.  [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].

Authors:  J Braun; J Zochling; E Märker-Hermann; G Stucki; H Böhm; M Rudwaleit; H Zeidler; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 2.  Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports.

Authors:  E S Strobel; E Fritschka
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi; Farhad Gharibdoost; Mahdi I Mahmoud; Pedram Paragomi; Mohammad Hossein Nicknam; Elham Farhadi; Mostafa Qorbani
Journal:  Caspian J Intern Med       Date:  2012

4.  Bone and stone in ankylosing spondylitis: osteoporosis and urolithiasis.

Authors:  Nurgül Arinci Incel; Figen Gökoğlu; Bariş Nacir; Nazmi Incel
Journal:  Clin Rheumatol       Date:  2005-12-07       Impact factor: 2.980

Review 5.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

6.  Coexisting ankylosing spondylitis and gouty arthritis.

Authors:  Huei-Huang Ho; Kuang-Hui Yu; Ji-Yih Chen; Ja-Liang Lin; Yeong-Jian Jan Wu; Shue-Fen Luo; Lieh-Bang Liou
Journal:  Clin Rheumatol       Date:  2007-03-14       Impact factor: 2.980

7.  [Renal manifestations in rheumatic diseases].

Authors:  K de Groot
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

Review 8.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

9.  Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease.

Authors:  Alessandro Giollo; Andrea Dalbeni; Giovanni Cioffi; Federica Ognibeni; Davide Gatti; Luca Idolazzi; Giovanni Orsolini; Pietro Minuz; Maurizio Rossini; Cristiano Fava; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2017-09-09       Impact factor: 2.980

10.  Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker.

Authors:  Sang-Hoon Lee; Eun Jung Lee; Sang Wan Chung; Ran Song; Joo-Young Moon; Sang-Ho Lee; Sung-Jig Lim; Yeon-Ah Lee; Seung-Jae Hong; Hyung-In Yang
Journal:  Rheumatol Int       Date:  2012-12-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.